148 related articles for article (PubMed ID: 8360140)
1. Peptidomimetic inhibitors of Ras farnesylation and function in whole cells.
Garcia AM; Rowell C; Ackermann K; Kowalczyk JJ; Lewis MD
J Biol Chem; 1993 Sep; 268(25):18415-8. PubMed ID: 8360140
[TBL] [Abstract][Full Text] [Related]
2. Bisubstrate inhibitors of farnesyltransferase: a novel class of specific inhibitors of ras transformed cells.
Manne V; Yan N; Carboni JM; Tuomari AV; Ricca CS; Brown JG; Andahazy ML; Schmidt RJ; Patel D; Zahler R
Oncogene; 1995 May; 10(9):1763-79. PubMed ID: 7753553
[TBL] [Abstract][Full Text] [Related]
3. Post-translational processing of purified human K-ras in Xenopus oocytes.
Kaplan JB; Sass PM
Cancer Commun; 1991; 3(12):383-8. PubMed ID: 16296004
[TBL] [Abstract][Full Text] [Related]
4. Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes.
Lerner EC; Qian Y; Blaskovich MA; Fossum RD; Vogt A; Sun J; Cox AD; Der CJ; Hamilton AD; Sebti SM
J Biol Chem; 1995 Nov; 270(45):26802-6. PubMed ID: 7592920
[TBL] [Abstract][Full Text] [Related]
5. Farnesylation of p21 Ras proteins in Xenopus oocytes.
Zhao J; Kung HF; Manne V
Cell Mol Biol Res; 1994; 40(4):313-21. PubMed ID: 7866432
[TBL] [Abstract][Full Text] [Related]
6. A non-peptide mimetic of Ras-CAAX: selective inhibition of farnesyltransferase and Ras processing.
Vogt A; Qian Y; Blaskovich MA; Fossum RD; Hamilton AD; Sebti SM
J Biol Chem; 1995 Jan; 270(2):660-4. PubMed ID: 7822292
[TBL] [Abstract][Full Text] [Related]
7. The CAAX peptidomimetic compound B581 specifically blocks farnesylated, but not geranylgeranylated or myristylated, oncogenic ras signaling and transformation.
Cox AD; Garcia AM; Westwick JK; Kowalczyk JJ; Lewis MD; Brenner DA; Der CJ
J Biol Chem; 1994 Jul; 269(30):19203-6. PubMed ID: 8034681
[TBL] [Abstract][Full Text] [Related]
8. MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling.
Graham TE; Pfeiffer JR; Lee RJ; Kusewitt DF; Martinez AM; Foutz T; Wilson BS; Oliver JM
J Immunol; 1998 Dec; 161(12):6733-44. PubMed ID: 9862703
[TBL] [Abstract][Full Text] [Related]
9. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
Yan N; Ricca C; Fletcher J; Glover T; Seizinger BR; Manne V
Cancer Res; 1995 Aug; 55(16):3569-75. PubMed ID: 7627966
[TBL] [Abstract][Full Text] [Related]
10. A peptide from the GAP-binding domain of the ras-p21 protein and azatyrosine block ras-induced maturation of Xenopus oocytes.
Chung DL; Brandt-Rauf P; Murphy RB; Nishimura S; Yamaizumi Z; Weinstein IB; Pincus MR
Anticancer Res; 1991; 11(4):1373-8. PubMed ID: 1746893
[TBL] [Abstract][Full Text] [Related]
11. Ras-dependent maturation of Xenopus oocytes is blocked by modified peptides of GTPase activating protein (GAP).
Losardo JE; Heimer E; Bekesi E; Prinzo K; Scheffler JE; Neri A
Int J Pept Protein Res; 1995 Feb; 45(2):194-9. PubMed ID: 7782168
[TBL] [Abstract][Full Text] [Related]
12. Potent inhibition of human tumor p21ras farnesyltransferase by A1A2-lacking p21ras CA1A2X peptidomimetics.
Nigam M; Seong CM; Qian Y; Hamilton AD; Sebti SM
J Biol Chem; 1993 Oct; 268(28):20695-8. PubMed ID: 8407887
[TBL] [Abstract][Full Text] [Related]
13. A peptide from the GAP-binding domain of the ras-p21 protein as well as azatyrosine block ras-induced maturation of Xenopus oocytes.
Chung DL; Brandt-Rauf P; Murphy RB; Nishimura S; Yamaizumi Z; Weinstein IB; Pincus MR
Biochem Biophys Res Commun; 1991 Dec; 181(3):1378-84. PubMed ID: 1764089
[TBL] [Abstract][Full Text] [Related]
14. Prenylation of mammalian Ras protein in Xenopus oocytes.
Kim R; Rine J; Kim SH
Mol Cell Biol; 1990 Nov; 10(11):5945-9. PubMed ID: 2233726
[TBL] [Abstract][Full Text] [Related]
15. Tetrapeptide inhibitors of protein farnesyltransferase: amino-terminal substitution in phenylalanine-containing tetrapeptides restores farnesylation.
Brown MS; Goldstein JL; Paris KJ; Burnier JP; Marsters JC
Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8313-6. PubMed ID: 1518863
[TBL] [Abstract][Full Text] [Related]
16. Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice.
Liu M; Bryant MS; Chen J; Lee S; Yaremko B; Li Z; Dell J; Lipari P; Malkowski M; Prioli N; Rossman RR; Korfmacher WA; Nomeir AA; Lin CC; Mallams AK; Doll RJ; Catino JJ; Girijavallabhan VM; Kirschmeier P; Bishop WR
Cancer Chemother Pharmacol; 1999; 43(1):50-8. PubMed ID: 9923541
[TBL] [Abstract][Full Text] [Related]
17. Palmitoylation of Ha-Ras facilitates membrane binding, activation of downstream effectors, and meiotic maturation in Xenopus oocytes.
Dudler T; Gelb MH
J Biol Chem; 1996 May; 271(19):11541-7. PubMed ID: 8626715
[TBL] [Abstract][Full Text] [Related]
18. Polylysine and CVIM sequences of K-RasB dictate specificity of prenylation and confer resistance to benzodiazepine peptidomimetic in vitro.
James GL; Goldstein JL; Brown MS
J Biol Chem; 1995 Mar; 270(11):6221-6. PubMed ID: 7890759
[TBL] [Abstract][Full Text] [Related]
19. Pseudopeptide inhibitors of Ras farnesyl-protein transferase.
Graham SL; deSolms SJ; Giuliani EA; Kohl NE; Mosser SD; Oliff AI; Pompliano DL; Rands E; Breslin MJ; Deana AA
J Med Chem; 1994 Mar; 37(6):725-32. PubMed ID: 8145221
[TBL] [Abstract][Full Text] [Related]
20. Arglabin-DMA, a plant derived sesquiterpene, inhibits farnesyltransferase.
Shaikenov TE; Adekenov SM; Williams RM; Prashad N; Baker FL; Madden TL; Newman R
Oncol Rep; 2001; 8(1):173-9. PubMed ID: 11115593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
